Expansion in Asia-Pacific with second subsidiary, following Australia, pivotal to enrolling patients in phase II trial ...

Japan’s Tanabe Pharma, formerly known as Mitsubishi Tanabe and now owned by Bain Capital, has obtained approval from the ...

ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...

Columnist Juliet Taylor and her late husband, Jeff, fought hard for precious holiday moments after he was diagnosed with ALS.

A local man is using what time he has left to to raise awareness about the financial and emotional toll A-L-S, also known as ...

A new wave of expressive, humanlike AI is helping people who cannot speak reclaim presence, connection, and dignity in ...

The man behind the Moose Jaw health centre that has claimed “a 100 per cent success rate in stopping the progression and in ...

Researchers developed a blood test that spots ALS with 90% accuracy. The 46-gene panel could cut diagnostic delays that now ...

Using machine learning models, researchers have identified a potential way to diagnose amyotrophic lateral sclerosis earlier ...

The study will be carried out at up to 60 ALS treatment centres across Canada, the EU, the US, Israel and the UK.

On November 17, 2025, Congressman Jason Crow introduced H.R. 6001, the Veterans with ALS Reporting Act. The purpose of this Act is to prioritize learning why disabled veterans are more likely than ...

FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official ...